COSCIENS Biopharma Inc. (CSCI) — Tangible Net Worth Ratio
COSCIENS Biopharma Inc. (CSCI) has a Tangible Net Worth Ratio of 100.0% as of June 2025. This metric is calculated by deducting intangible assets ($0.00) from net assets ($7.10 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See net assets of COSCIENS Biopharma Inc. for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
COSCIENS Biopharma Inc. Tangible Net Worth Ratio (1996–2024)
This chart shows how COSCIENS Biopharma Inc.'s Tangible Net Worth Ratio has changed across 21 annual periods from 1996 to 2024. As of June 2025, the ratio stands at 100.0%, reflecting net assets of $7.10 Million with intangible assets of $0.00 USD. Also explore COSCIENS Biopharma Inc. annual equity growth to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for COSCIENS Biopharma Inc. (1996–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for COSCIENS Biopharma Inc. from 1996 to 2024, covering 21 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market cap of COSCIENS Biopharma Inc..
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 100.0% | $13.16 Million | $0.00 | $35.07 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $21.04 Million | $7.00K | $23.75 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $23.79 Million | $9.27K | $27.80 Million | ▲ +0.0 pp |
| 2021 | 99.9% | $21.74 Million | $12.20K | $24.35 Million | ▲ +0.0 pp |
| 2020 | 99.9% | $19.06 Million | $14.52K | $22.92 Million | ▲ +0.0 pp |
| 2019 | 99.9% | $17.08 Million | $16.44K | $20.88 Million | ▲ +0.0 pp |
| 2018 | 99.9% | $17.04 Million | $17.94K | $18.59 Million | ▲ +0.4 pp |
| 2017 | 99.5% | $17.93 Million | $90.00K | $22.11 Million | ▼ -0.4 pp |
| 2016 | 99.9% | $16.67 Million | $22.59K | $19.64 Million | ▲ +0.3 pp |
| 2015 | 99.6% | $5.68 Million | $24.02K | $11.32 Million | ▲ +1.3 pp |
| 2014 | 98.3% | $1.80 Million | $31.26K | $6.62 Million | ▲ +25.4 pp |
| 2013 | 72.9% | $229.62K | $62.22K | $4.79 Million | ▲ +513.6 pp |
| 2012 | -440.7% | $13.63K | $73.72K | $3.91 Million | ▼ -533.7 pp |
| 2011 | 93.0% | $507.11K | $35.26K | $4.09 Million | ▲ +38.6 pp |
| 2007 | 54.4% | $1.57 Million | $715.10K | $4.63 Million | ▲ +163.2 pp |
| 2006 | -108.8% | $260.64K | $544.14K | $1.77 Million | ▲ +4.2 pp |
| 2005 | -112.9% | $397.23K | $845.83K | $2.08 Million | ▼ -212.9 pp |
| 2004 | 100.0% | $94.89K | $0.00 | $1.43 Million | ▲ +0.0 pp |
| 2003 | 100.0% | $294.75K | $0.00 | $968.03K | ▲ +63.8 pp |
| 1997 | 36.2% | $6.57 Million | $4.19 Million | $9.15 Million | ▲ +11.2 pp |
| 1996 | 25.0% | $5.84 Million | $4.38 Million | $13.57 Million | — |